Vor Biopharma Inc.·3

Apr 1, 5:15 PM ET

TCG Crossover Fund II, L.P. 3

3 · Vor Biopharma Inc. · Filed Apr 1, 2026

Insider Transaction Report

Form 3
Period: 2026-03-30
Holdings
  • Common Stock

    [F1]
    (indirect: See footnote)
    2,836,539
  • Common Stock

    [F2]
    (indirect: See footnote)
    2,836,539
Footnotes (2)
  • [F1]These securities are held of record by TCG Crossover Fund II, L.P. (TCG Crossover II). TCG Crossover GP II, LLC (TCG Crossover GP II) is the general partner of TCG Crossover II and may be deemed to have voting, investment, and dispositive power with respect to these securities. Chen Yu is the sole managing member of TCG Crossover GP II and may be deemed to share voting, investment and dispositive power with respect to these securities.
  • [F2]These securities are held of record by TCG Crossover Fund III, L.P. (TCG Crossover III). TCG Crossover GP III, LLC (TCG Crossover GP III) is the general partner of TCG Crossover III and may be deemed to have voting, investment, and dispositive power with respect to these securities. Chen Yu is the sole managing member of TCG Crossover GP III and may be deemed to share voting, investment and dispositive power with respect to these securities.

Documents

1 file
  • 3
    ownership.xmlPrimary

    3